Arizona State Retirement System’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.63M | Sell |
28,886
-356
| -1% | -$44.7K | 0.02% | 523 |
|
|
2025
Q1 | $3.23M | Sell |
29,242
-60
| -0.2% | -$6.64K | 0.02% | 541 |
|
|
2024
Q4 | $4M | Buy |
29,302
+469
| +2% | +$64K | 0.02% | 500 |
|
|
2024
Q3 | $3.32M | Buy |
28,833
+1,499
| +5% | +$173K | 0.02% | 557 |
|
|
2024
Q2 | $3.76M | Buy |
27,334
+310
| +1% | +$42.7K | 0.03% | 476 |
|
|
2024
Q1 | $3.73M | Buy |
27,024
+185
| +0.7% | +$25.5K | 0.03% | 490 |
|
|
2023
Q4 | $3.54M | Buy |
26,839
+219
| +0.8% | +$28.9K | 0.03% | 491 |
|
|
2023
Q3 | $2.99M | Buy |
26,620
+4
| +0% | +$450 | 0.03% | 504 |
|
|
2023
Q2 | $2.51M | Sell |
26,616
-1,333
| -5% | -$126K | 0.02% | 582 |
|
|
2023
Q1 | $2.83M | Buy |
27,949
+878
| +3% | +$88.9K | 0.03% | 550 |
|
|
2022
Q4 | $3.23M | Buy |
27,071
+829
| +3% | +$99K | 0.03% | 480 |
|
|
2022
Q3 | $2.79M | Sell |
26,242
-340
| -1% | -$36.1K | 0.03% | 509 |
|
|
2022
Q2 | $2.59M | Buy |
26,582
+175
| +0.7% | +$17.1K | 0.03% | 544 |
|
|
2022
Q1 | $2.48M | Buy |
26,407
+637
| +2% | +$59.7K | 0.02% | 605 |
|
|
2021
Q4 | $2.2M | Sell |
25,770
-763
| -3% | -$65K | 0.02% | 692 |
|
|
2021
Q3 | $2.55M | Sell |
26,533
-20
| -0.1% | -$1.92K | 0.02% | 617 |
|
|
2021
Q2 | $2.58M | Buy |
26,553
+962
| +4% | +$93.6K | 0.02% | 630 |
|
|
2021
Q1 | $2.49M | Buy |
25,591
+187
| +0.7% | +$18.2K | 0.02% | 635 |
|
|
2020
Q4 | $2.44M | Sell |
25,404
-1,440
| -5% | -$138K | 0.02% | 600 |
|
|
2020
Q3 | $2.58M | Buy |
26,844
+6,421
| +31% | +$617K | 0.03% | 532 |
|
|
2020
Q2 | $2.49M | Buy |
20,423
+289
| +1% | +$35.3K | 0.04% | 438 |
|
|
2020
Q1 | $1.74M | Buy |
+20,134
| New | +$1.74M | 0.03% | 506 |
|